Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
67.1%  /
73.1%
29.2x
26.7x
7.4x
25.2%
102.4%
..
0.0%
12.3% 
44.9%  /
69.2%
103.5x
92.7x
11.7x
11.3%
25.6%
2025-10-29
0.0%
2.1% 
13.3%  /
11.3%
17.5x
21.7x
3.5x
20.1%
2.9%
2025-10-30
0.0%
0.8% 
1.0%  /
6.5%
11.8x
13.8x
0.3x
2.6%
-4.3%
..
2.9%
-12.1% 
3.3%  /
2.0%
18.2x
11.8x
3.2x
18.0%
-4.4%
2026-02-05
1.1%
-1.3% 
6.1%  /
1.5%
22.7x
17.1x
5.6x
24.8%
20.6%
2025-10-29
1.1%
3.9% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2025-10-30
#reports #WEX

[WEX](https://eninvs.com/all.php?name=WEX) (Payment processing service provider) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +3.9% YoY (vs -2.1% in previous quarter and historical rate +6.0%)
- EBITDA -3.5% YoY (vs -3.0% in previous quarter and historical rate +25.7%)
- EBITDA margin 32.2% decreased compared to 34.7% same period last year
- Net Debt decreased by $443 mln over the past reporting period (6.6% of market cap)
- FCF (LTM) +$0.6 bln (positive), 8.7% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 2.6x

2025-10-30
#reports #VRSK

[Verisk Analytics](https://eninvs.com/all.php?name=VRSK) (Analytical service provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192498)
(2025-10-29, Before Market Open):

- Revenue +5.9% YoY (vs +7.8% in previous quarter and historical rate +0.5%)
- EBITDA +7.9% YoY (vs +7.9% in previous quarter and historical rate +4.8%)
- EBITDA margin 60.7% increased compared to 59.6% same period last year
- Net Debt decreased by $18 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 18.5x compared to historical level (75th percentile) of 23.4x
- EV/Sales multiple is 10.5x

At the opening of the session the share price went down -10.2% vs S&P500 +0.3%
2025-10-30
#reports #VRRM

[Verra Mobility](https://eninvs.com/all.php?name=VRRM) (Security and Protection Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192497)
(2025-10-29, After Market Close):

- Revenue +15.9% YoY (vs +6.3% in previous quarter and historical rate +9.2%)
- EBITDA +13.2% YoY (vs +3.4% in previous quarter and historical rate -8.1%)
- EBITDA margin 39.3% decreased compared to 40.3% same period last year
- Net Debt decreased by $34 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 17.7x compared to historical level (75th percentile) of 18.2x
- EV/Sales multiple is 4.9x

2025-10-30
#reports #VNDA

[Vanda Pharmaceuticals](https://eninvs.com/all.php?name=VNDA) (Small molecule drugs developer) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +16.7% YoY (vs +6.0% in previous quarter and historical rate -3.8%)
- EBITDA margin -55.4% decreased compared to -22.9% same period last year
- Net Debt increased by $31 mln over the past reporting period (9.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 16.3% of market cap
- EV/Sales multiple is 0.1x

2025-10-30
#reports #UDMY

[Udemy, Inc.](https://eninvs.com/all.php?name=UDMY) (Education and Training Services) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +0.5% YoY (vs +3.1% in previous quarter and historical rate +10.1%)
- EBITDA margin 11.7% increased compared to -4.1% same period last year
- Net Debt increased by $24 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) +$0 bln (positive), 4.3% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 43.2x
- EV/Sales multiple is 0.7x

2025-10-30
#reports #TYL

[Tyler Technologies](https://eninvs.com/all.php?name=TYL) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192495)
(2025-10-29, After Market Close):

- Revenue +9.8% YoY (vs +10.2% in previous quarter and historical rate +7.9%)
- EBITDA -9.5% YoY (vs +56.6% in previous quarter and historical rate +13.6%)
- EBITDA margin 22.3% decreased compared to 27.1% same period last year
- Net Debt decreased by $56 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 41.2x compared to historical level (75th percentile) of 55.6x
- EV/Sales multiple is 8.8x

2025-10-30
#reports #TTMI

[TTM Technologies](https://eninvs.com/all.php?name=TTMI) (Printed circuit board manufacturer) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue +22% YoY (vs +20.8% in previous quarter and historical rate +4.7%)
- EBITDA +25% YoY (vs +40.4% in previous quarter and historical rate +23.5%)
- EBITDA margin 13.9% increased compared to 13.6% same period last year
- Net Debt decreased by $43 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 20.5x compared to historical level (75th percentile) of 11.7x
- EV/Sales multiple is 2.5x

2025-10-30
#reports #TMDX

[TransMedics Group](https://eninvs.com/all.php?name=TMDX) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192493)
(2025-10-29, After Market Close):

- Revenue +32.1% YoY (vs +37.7% in previous quarter and historical rate +109.1%)
- EBITDA +100% YoY (vs +230.8% in previous quarter and historical rate +125.0%)
- EBITDA margin 20.8% increased compared to 13.8% same period last year
- Net Debt decreased by $65 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 37.2x compared to historical level (75th percentile) of 64.7x
- EV/Sales multiple is 8.1x

2025-10-30
#reports #TKR

[The Timken Company](https://eninvs.com/all.php?name=TKR) (Power transmission products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192492)
(2025-10-29, Before Market Open):

- Revenue +2.7% YoY (vs -0.8% in previous quarter and historical rate +1.1%)
- EBITDA -2% YoY (vs -7.2% in previous quarter and historical rate +4.7%)
- EBITDA margin 17.1% decreased compared to 17.9% same period last year
- Net Debt decreased by $123 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 9.6x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +7.5% vs S&P500 +0.3%
2025-10-30
#reports #TDOC

[Teladoc Health](https://eninvs.com/all.php?name=TDOC) (Health care provider) reported for 2025 q3
(2025-10-29, After Market Close):

- Revenue -2.3% YoY (vs -1.6% in previous quarter and historical rate +3.1%)
- EBITDA margin -7.8% decreased compared to -6.6% same period last year
- Net Debt decreased by $40 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/Sales multiple is 0.4x

2025-10-30
#reports #SNCY

[Sun Country Airlines Holdings, Inc.](https://eninvs.com/all.php?name=SNCY) (Airlines) reported for 2025 q3
(2025-10-29, Before Market Open):

- Revenue +2.8% YoY (vs +3.9% in previous quarter and historical rate +27.5%)
- EBITDA -2.8% YoY (vs +13.9% in previous quarter and historical rate +51.8%)
- EBITDA margin 13.7% decreased compared to 14.5% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.2% of market cap)
- EV/EBITDA multiple is 1.8x compared to historical level (75th percentile) of 4.6x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +0.1% vs S&P500 +0.3%
2025-10-30
#reports #SCL

[Stepan Company](https://eninvs.com/all.php?name=SCL) (Specialty and intermediate chemicals manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SCL&q=2025 q3&id=892401)
(2025-10-29, Before Market Open):

- Revenue +7.9% YoY (vs +7.0% in previous quarter and historical rate -7.6%)
- EBITDA -9.5% YoY (vs -3.2% in previous quarter and historical rate +1.5%)
- EBITDA margin 11.4% decreased compared to 13.5% same period last year
- Net Debt decreased by $26 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 21.2% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 19.7x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -1.0% vs S&P500 +0.3%
2025-10-30
#reports #SCI

[Service Corporation International](https://eninvs.com/all.php?name=SCI) (Funeral service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SCI&q=2025 q3&id=892400)
(2025-10-29, After Market Close):

- Revenue +4.3% YoY (vs +3.0% in previous quarter and historical rate +1.4%)
- EBITDA +6.1% YoY (vs +2.6% in previous quarter and historical rate +29.8%)
- EBITDA margin 29.6% increased compared to 29.1% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 13x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 4x

2025-10-30
#reports #PI

[Impinj](https://eninvs.com/all.php?name=PI) (Communication Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192485)
(2025-10-29, After Market Close):

- Revenue +1.1% YoY (vs -3.9% in previous quarter and historical rate +18.0%)
- EBITDA +150% YoY (vs +25.0% in previous quarter and historical rate +47.9%)
- EBITDA margin 5.2% increased compared to 2.1% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 711.4x compared to historical level (75th percentile) of 1345.5x
- EV/Sales multiple is 19.8x

2025-10-30
#reports #PAG

[Penske Automotive Group](https://eninvs.com/all.php?name=PAG) (Transportation services provider) reported for 2025 q3
(2025-10-29, Before Market Open):

- Revenue +1.4% YoY (vs -0.5% in previous quarter and historical rate +4.3%)
- EBITDA -4.5% YoY (vs +3.4% in previous quarter and historical rate -4.1%)
- EBITDA margin 4.4% decreased compared to 4.7% same period last year
- Net Debt decreased by $410 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 13.7x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -5.0% vs S&P500 +0.3%
2025-10-30
#reports #OTIS

[Otis Worldwide](https://eninvs.com/all.php?name=OTIS) (Elevator manufacturer) reported for 2025 q3
(2025-10-29, Before Market Open):

- Revenue +4% YoY (vs -0.2% in previous quarter and historical rate +1.2%)
- EBITDA +53.3% YoY (vs -3.3% in previous quarter and historical rate +6.2%)
- EBITDA margin 17.1% increased compared to 11.6% same period last year
- Net Debt increased by $185 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 20.7x compared to historical level (75th percentile) of 21.3x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +3.0% vs S&P500 +0.3%
2025-10-30
#reports #OSK

[Oshkosh Corporation](https://eninvs.com/all.php?name=OSK) (Vehicle manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192484)
(2025-10-29, Before Market Open):

- Revenue -1.9% YoY (vs -4.0% in previous quarter and historical rate +10.0%)
- EBITDA -0.3% YoY (vs +12.6% in previous quarter and historical rate +72.1%)
- EBITDA margin 11.8% increased compared to 11.6% same period last year
- Net Debt decreased by $312 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 9.1x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went down -4.4% vs S&P500 +0.3%
2025-10-30
#reports #OPK

[OPKO Health](https://eninvs.com/all.php?name=OPK) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192483)
(2025-10-29, After Market Close):

- Revenue -12.6% YoY (vs -13.7% in previous quarter and historical rate -16.5%)
- EBITDA +82.9% YoY (vs -3400.0% in previous quarter and historical rate +14.3%)
- EBITDA margin 49.3% increased compared to 23.6% same period last year
- Net Debt decreased by $141 mln over the past reporting period (12.5% of market cap)
- FCF (LTM) +$0.5 bln (positive), 40.6% of market cap
- EV/Sales multiple is 1.6x

2025-10-30
#reports #MUSA

[Murphy USA](https://eninvs.com/all.php?name=MUSA) (Motor fuel supplier) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=MUSA&q=2025 q3&id=892366)
(2025-10-29, After Market Close):

- Revenue -2.5% YoY (vs -8.2% in previous quarter and historical rate -4.9%)
- EBITDA -4.2% YoY (vs +3.3% in previous quarter and historical rate -3.2%)
- EBITDA margin 5.3% has not changed compared to 5.4% same period last year
- Net Debt increased by $175 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0.3 bln (negative), 3.5% of market cap
- EV/EBITDA multiple is 10.6x compared to historical level (75th percentile) of 11.9x
- EV/Sales multiple is 0.5x

2025-10-30
#reports #MGPI

[MGP Ingredients](https://eninvs.com/all.php?name=MGPI) (Liquor manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192476)
(2025-10-29, Before Market Open):

- Revenue -18.6% YoY (vs -24.1% in previous quarter and historical rate -7.7%)
- EBITDA -28.6% YoY (vs -50.0% in previous quarter and historical rate -30.3%)
- EBITDA margin 19.1% decreased compared to 21.7% same period last year
- Net Debt decreased by $25 mln over the past reporting period (4.7% of market cap)
- FCF (LTM) -$0 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 23.3x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +8.6% vs S&P500 +0.3%
2025-10-30
#reports #MDXG

[MiMedx Group](https://eninvs.com/all.php?name=MDXG) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=192474)
(2025-10-29, After Market Close):

- Revenue +35.7% YoY (vs +13.8% in previous quarter and historical rate +14.9%)
- EBITDA +100% YoY (vs -68.8% in previous quarter and historical rate +77.0%)
- EBITDA margin 19.3% increased compared to 13.1% same period last year
- Net Debt decreased by $24 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0 bln (positive), 2.8% of market cap
- EV/EBITDA multiple is 21.3x compared to historical level (75th percentile) of 28.4x
- EV/Sales multiple is 2.4x